| __timestamp | PTC Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 855506000 |
| Thursday, January 1, 2015 | 121816000 | 996170000 |
| Friday, January 1, 2016 | 117633000 | 1047690000 |
| Sunday, January 1, 2017 | 117456000 | 1324625000 |
| Monday, January 1, 2018 | 171984000 | 1416476000 |
| Tuesday, January 1, 2019 | 257452000 | 1754540000 |
| Wednesday, January 1, 2020 | 477643000 | 1829537000 |
| Friday, January 1, 2021 | 540684000 | 3051100000 |
| Saturday, January 1, 2022 | 651496000 | 2540300000 |
| Sunday, January 1, 2023 | 666563000 | 3162900000 |
| Monday, January 1, 2024 | 3630300000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Vertex Pharmaceuticals Incorporated and PTC Therapeutics, Inc. have been at the forefront of this race, with their research and development (R&D) spending reflecting their commitment to innovation. Over the past decade, Vertex has consistently outspent PTC, with its R&D expenses peaking at approximately 3.16 billion in 2023, a staggering 375% increase from 2014. In contrast, PTC's R&D spending grew by over 730% during the same period, reaching around 667 million in 2023. This data highlights Vertex's dominant position in the industry, yet PTC's rapid growth in R&D investment signals its rising ambition. As these companies continue to prioritize innovation, their R&D strategies will be crucial in shaping the future of pharmaceuticals.
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Exelixis, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
PTC Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: PTC Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: PTC Therapeutics, Inc. vs Viridian Therapeutics, Inc.